Nucleic acid sequences in the form of viral vector or non-viral vector for medical purposes, namely, gene therapy; biochemical preparations for medical purposes, namely, gene based therapeutics for the treatment of diseases, namely, infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases; pharmaceutical preparations for the prevention or treatment of viral infections such as those caused by SARS-CoV-2, SARS-CoV-1, or MERS-CoV
Pharmaceuticals